In the Journals

This feature offers timely executive summaries of the most relevant journals in hepatology. Through peer “Perspectives,” full bibliographical information and links to the original journal abstract, In the Journals are a step wider and deeper than journal reviews health care professionals may be accustomed.

In the Journals

Public insurance a risk factor for worse liver transplant waitlist outcomes

August 30, 2019
Patients with hepatocellular carcinoma on a liver transplantation waitlist who had public insurance had worse waitlist outcomes compared with those…
In the Journals

Liver cancer outcomes improving as physicians gain experience with Nexavar

August 29, 2019
Increasing physician experience in the management of Nexavar-related adverse events has led to longer treatment duration and improved overall…
In the Journals

Janssen, Arrowhead initiate dosing in multi-combination HBV study

August 29, 2019
Janssen Pharmaceuticals initiated patient dosing in a phase 2b study of different regimens for the treatment of chronic hepatitis B including…
In the Journals

Incremental liver fat increases raise diabetes, metabolic syndrome risks

August 27, 2019
Increases in liver fat correlated with development of cardiovascular disease risk factors including incident diabetes and metabolic syndrome…
In the Journals

Patients with ‘double negative’ HBV at treatment end less likely to relapse

August 27, 2019
Results from two independent cohorts revealed that patients who had negative test results for both hepatitis B DNA and hepatitis B RNA at the end of…
In the Journals

HCV clearance reduces diabetes, kidney disease, stroke risk

August 23, 2019
Sustained virologic response after treatment for hepatitis C correlated with a reduced risk for several extrahepatic manifestations including type 2…
In the Journals

NAFLD fibrosis score, FIB-4 increase at similar rate in advanced fibrosis

August 23, 2019
Nonalcoholic fatty liver disease fibrosis scores and Fibrosis-4 index scores increased longitudinally and at a higher rate in those with fatty liver…
In the Journals

Denosumab increases bone mineral density in patients with PBC

August 22, 2019
Long-term treatment with denosumab increased bone mineral density without any adverse effects in patients with autoimmune liver disease, specifically…
In the Journals

Military combat service linked to an increase in HBV exposure

August 21, 2019
The prevalence of exposure to hepatitis B among veterans was highest among those with traditional risk factors and independently related to military…
In the Journals

Strength training ‘recovers lost muscle mass’ from cirrhosis

August 20, 2019
Supervised progressive resistance training increased muscle strength and size in patients with compensated cirrhosis while also providing beneficial…